{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:57:50Z","timestamp":1792663070151,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many novel therapies to treat myocardial infarction (MI), yielding promising results in animal models, nowadays failed in clinical trials for several reasons. The most used animal MI model is based on permanent ligation of the left anterior descending (LAD) coronary artery in healthy mice resulting in transmural MI, while in clinical practice reperfusion is usually accomplished by primary percutaneous coronary interventions (PCI) limiting myocardial damage and inducing myocardial ischemia\u2013reperfusion (MI-R) injury. To evaluate a more similar murine MI model we compared MI-R injury to unreperfused MI in hypercholesterolemic apolipoprotein (APO)E*3-Leiden mice regarding effects on cardiac function, left ventricular (LV) remodeling and inflammation. Both MI-R and MI resulted in significant LV dilation and impaired cardiac function after 3\u00a0weeks. Although LV dilation, displayed by end-diastolic (EDV) and end-systolic volumes (ESV), and infarct size (IS) were restricted following MI-R compared to MI (respectively by 27.6% for EDV, 39.5% ESV, 36.0% IS), cardiac function was not preserved. LV-wall thinning was limited with non-transmural LV fibrosis in the MI-R group (66.7%). Two days after inducing myocardial ischemia, local leucocyte infiltration in the infarct area was decreased following MI-R compared to MI (36.6%), whereas systemic circulating monocytes were increased in both groups compared to sham (130.0% following MI-R and 120.0% after MI). Both MI-R and MI models against the background of a hypercholesterolemic phenotype appear validated experimental models, however reduced infarct size, restricted LV remodeling as well as a different distributed inflammatory response following MI-R resemble the contemporary clinical outcome regarding primary PCI more accurately which potentially provides better predictive value of experimental therapies in successive clinical trials.<\/jats:p>","DOI":"10.1038\/s41598-020-73608-w","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T10:04:27Z","timestamp":1601978667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effects on cardiac function, remodeling and inflammation following myocardial ischemia\u2013reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice"],"prefix":"10.1038","volume":"10","author":[{"given":"Niek J.","family":"Pluijmert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy I.","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina H.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H. A.","family":"Quax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe E.","family":"Atsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"73608_CR1","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMra1216063","volume":"368","author":"P Libby","year":"2013","unstructured":"Libby, P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med. 368, 2004\u20132013. https:\/\/doi.org\/10.1056\/NEJMra1216063 (2013).","journal-title":"N. Engl. J. Med."},{"key":"73608_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.111.047431","volume":"125","author":"A Arbab-Zadeh","year":"2012","unstructured":"Arbab-Zadeh, A., Nakano, M., Virmani, R. & Fuster, V. Acute coronary events. Circulation 125, 1147\u20131156. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.047431 (2012).","journal-title":"Circulation"},{"key":"73608_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39, 119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393 (2018).","journal-title":"Eur. Heart J."},{"key":"73608_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1056\/NEJM200008103430602","volume":"343","author":"A Schomig","year":"2000","unstructured":"Schomig, A. et al. Coronary stenting plus platelet glycoprotein IIb\/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus thrombolysis for occluded coronary arteries in patients with acute myocardial infarction study investigators. N. Engl. J. Med. 343, 385\u2013391. https:\/\/doi.org\/10.1056\/NEJM200008103430602 (2000).","journal-title":"N. Engl. J. Med."},{"key":"73608_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121\u20131135. https:\/\/doi.org\/10.1056\/NEJMra071667 (2007).","journal-title":"N. Engl. J. Med."},{"key":"73608_CR6","first-page":"8786","volume":"8","author":"S Hashmi","year":"2015","unstructured":"Hashmi, S. & Al-Salam, S. Acute myocardial infarction and myocardial ischemia-reperfusion injury: a comparison. Int. J. Clin. Exp. Pathol. 8, 8786\u20138796 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"73608_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/cvr\/cvu225","volume":"104","author":"S Lecour","year":"2014","unstructured":"Lecour, S. et al. ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies. Cardiovasc. Res. 104, 399\u2013411. https:\/\/doi.org\/10.1093\/cvr\/cvu225 (2014).","journal-title":"Cardiovasc. Res."},{"key":"73608_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1242\/dmm.016741","volume":"7","author":"K McCafferty","year":"2014","unstructured":"McCafferty, K., Forbes, S., Thiemermann, C. & Yaqoob, M. M. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis. Model. Mech. 7, 1321\u20131333. https:\/\/doi.org\/10.1242\/dmm.016741 (2014).","journal-title":"Dis. Model. Mech."},{"key":"73608_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12265-015-9606-8","volume":"8","author":"E Lara-Pezzi","year":"2015","unstructured":"Lara-Pezzi, E. et al. Guidelines for translational research in heart failure. J. Cardiovasc. Transl. Res. 8, 3\u201322. https:\/\/doi.org\/10.1007\/s12265-015-9606-8 (2015).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"73608_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvx049","volume":"113","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy, D. J. et al. Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc. Res. 113, 564\u2013585. https:\/\/doi.org\/10.1093\/cvr\/cvx049 (2017).","journal-title":"Cardiovasc. Res."},{"key":"73608_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","volume":"113","author":"HE Botker","year":"2018","unstructured":"Botker, H. E. et al. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res. Cardiol. 113, 39. https:\/\/doi.org\/10.1007\/s00395-018-0696-8 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"73608_CR12","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","volume":"314","author":"ML Lindsey","year":"2018","unstructured":"Lindsey, M. L. et al. Guidelines for experimental models of myocardial ischemia and infarction. Am. J. Physiol. Heart Circ. Physiol. 314, H812\u2013H838. https:\/\/doi.org\/10.1152\/ajpheart.00335.2017 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"73608_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1161\/CIRCRESAHA.113.300765","volume":"113","author":"RS Vander Heide","year":"2013","unstructured":"Vander Heide, R. S. & Steenbergen, C. Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ. Res. 113, 464\u2013477. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300765 (2013).","journal-title":"Circ. Res."},{"key":"73608_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1230719","volume":"339","author":"FK Swirski","year":"2013","unstructured":"Swirski, F. K. & Nahrendorf, M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161\u2013166. https:\/\/doi.org\/10.1126\/science.1230719 (2013).","journal-title":"Science"},{"key":"73608_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1172\/JCI29950","volume":"117","author":"FK Swirski","year":"2007","unstructured":"Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Investig. 117, 195\u2013205. https:\/\/doi.org\/10.1172\/JCI29950 (2007).","journal-title":"J. Clin. Investig."},{"key":"73608_CR16","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1161\/CIRCRESAHA.113.300890","volume":"112","author":"M Nahrendorf","year":"2013","unstructured":"Nahrendorf, M. & Swirski, F. K. Monocyte and macrophage heterogeneity in the heart. Circ. Res. 112, 1624\u20131633. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300890 (2013).","journal-title":"Circ. Res."},{"key":"73608_CR17","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","volume":"121","author":"M Nahrendorf","year":"2010","unstructured":"Nahrendorf, M., Pittet, M. J. & Swirski, F. K. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121, 2437\u20132445. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.916346 (2010).","journal-title":"Circulation"},{"key":"73608_CR18","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"M Nahrendorf","year":"2007","unstructured":"Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037\u20133047. https:\/\/doi.org\/10.1084\/jem.20070885 (2007).","journal-title":"J. Exp. Med."},{"key":"73608_CR19","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jacc.2009.08.089","volume":"55","author":"P Panizzi","year":"2010","unstructured":"Panizzi, P. et al. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J. Am. Coll. Cardiol. 55, 1629\u20131638. https:\/\/doi.org\/10.1016\/j.jacc.2009.08.089 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"73608_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","volume":"73","author":"SM Davidson","year":"2019","unstructured":"Davidson, S. M. et al. Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 89\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.086 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"73608_CR21","doi-asserted-by":"publisher","first-page":"e1001482","DOI":"10.1371\/journal.pmed.1001482","volume":"10","author":"CR Hooijmans","year":"2013","unstructured":"Hooijmans, C. R. & Ritskes-Hoitinga, M. Progress in using systematic reviews of animal studies to improve translational research. PLoS Med. 10, e1001482. https:\/\/doi.org\/10.1371\/journal.pmed.1001482 (2013).","journal-title":"PLoS Med."},{"key":"73608_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jacc.2014.01.014","volume":"63","author":"IM Seropian","year":"2014","unstructured":"Seropian, I. M., Toldo, S., Van Tassell, B. W. & Abbate, A. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J. Am. Coll. Cardiol. 63, 1593\u20131603. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.014 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"73608_CR23","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","volume":"120","author":"G Heusch","year":"2017","unstructured":"Heusch, G. Critical issues for the translation of cardioprotection. Circ. Res. 120, 1477\u20131486. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310820 (2017).","journal-title":"Circ. Res."},{"key":"73608_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14931","author":"I Andreadou","year":"2019","unstructured":"Andreadou, I. et al. Hyperlipidaemia and cardioprotection: animal models for translational studies. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.14931 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"73608_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.yjmcc.2011.02.016","volume":"50","author":"G Heusch","year":"2011","unstructured":"Heusch, G., Skyschally, A. & Schulz, R. The in-situ pig heart with regional ischemia\/reperfusion\u2014ready for translation. J. Mol. Cell Cardiol. 50, 951\u2013963. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.02.016 (2011).","journal-title":"J. Mol. Cell Cardiol."},{"key":"73608_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/CIRCRESAHA.118.313947","volume":"123","author":"G Heusch","year":"2018","unstructured":"Heusch, G., Skyschally, A. & Kleinbongard, P. translation, translation. Circ. Res. 123, 931\u2013933. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313947 (2018).","journal-title":"Circ. Res."},{"key":"73608_CR27","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","volume":"27","author":"S Zadelaar","year":"2007","unstructured":"Zadelaar, S. et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 27, 1706\u20131721. https:\/\/doi.org\/10.1161\/ATVBAHA.107.142570 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"73608_CR28","doi-asserted-by":"publisher","first-page":"H660","DOI":"10.1152\/ajpheart.1999.277.2.H660","volume":"277","author":"LH Michael","year":"1999","unstructured":"Michael, L. H. et al. Myocardial infarction and remodeling in mice: effect of reperfusion. Am. J. Physiol. 277, H660-668. https:\/\/doi.org\/10.1152\/ajpheart.1999.277.2.H660 (1999).","journal-title":"Am. J. Physiol."},{"key":"73608_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1113\/expphysiol.2004.027649","volume":"89","author":"T De Celle","year":"2004","unstructured":"De Celle, T. et al. Long-term structural and functional consequences of cardiac ischaemia-reperfusion injury in vivo in mice. Exp. Physiol. 89, 605\u2013615. https:\/\/doi.org\/10.1113\/expphysiol.2004.027649 (2004).","journal-title":"Exp. Physiol."},{"key":"73608_CR30","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/nprot.2006.188","volume":"1","author":"NF Huang","year":"2006","unstructured":"Huang, N. F. et al. A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat. Protoc. 1, 1596\u20131609. https:\/\/doi.org\/10.1038\/nprot.2006.188 (2006).","journal-title":"Nat. Protoc."},{"key":"73608_CR31","doi-asserted-by":"publisher","first-page":"H1812","DOI":"10.1152\/ajpheart.1998.274.5.H1812","volume":"274","author":"RD Patten","year":"1998","unstructured":"Patten, R. D. et al. Ventricular remodeling in a mouse model of myocardial infarction. Am. J. Physiol. 274, H1812-1820. https:\/\/doi.org\/10.1152\/ajpheart.1998.274.5.H1812 (1998).","journal-title":"Am. J. Physiol."},{"key":"73608_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phrs.2008.06.007","volume":"58","author":"NG Frangogiannis","year":"2008","unstructured":"Frangogiannis, N. G. The immune system and cardiac repair. Pharmacol. Res. 58, 88\u2013111. https:\/\/doi.org\/10.1016\/j.phrs.2008.06.007 (2008).","journal-title":"Pharmacol. Res."},{"key":"73608_CR33","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/01.cir.81.4.1161","volume":"81","author":"MA Pfeffer","year":"1990","unstructured":"Pfeffer, M. A. & Braunwald, E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81, 1161\u20131172. https:\/\/doi.org\/10.1161\/01.cir.81.4.1161 (1990).","journal-title":"Circulation"},{"key":"73608_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0002-9440(10)63154-9","volume":"164","author":"O Dewald","year":"2004","unstructured":"Dewald, O. et al. Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. Am. J. Pathol. 164, 665\u2013677. https:\/\/doi.org\/10.1016\/S0002-9440(10)63154-9 (2004).","journal-title":"Am. J. Pathol."},{"key":"73608_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.carpath.2005.10.006","volume":"15","author":"S Vandervelde","year":"2006","unstructured":"Vandervelde, S. et al. Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. Cardiovasc. Pathol. 15, 83\u201390. https:\/\/doi.org\/10.1016\/j.carpath.2005.10.006 (2006).","journal-title":"Cardiovasc. Pathol."},{"key":"73608_CR36","doi-asserted-by":"publisher","first-page":"e0217582","DOI":"10.1371\/journal.pone.0217582","volume":"14","author":"NJ Pluijmert","year":"2019","unstructured":"Pluijmert, N. J. et al. Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury. PLoS ONE 14, e0217582. https:\/\/doi.org\/10.1371\/journal.pone.0217582 (2019).","journal-title":"PLoS ONE"},{"key":"73608_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/09537100600800412","volume":"18","author":"G Avramakis","year":"2007","unstructured":"Avramakis, G. et al. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina. Platelets 18, 16\u201323. https:\/\/doi.org\/10.1080\/09537100600800412 (2007).","journal-title":"Platelets"},{"key":"73608_CR38","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","volume":"115","author":"I Andreadou","year":"2019","unstructured":"Andreadou, I. et al. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc. Res. 115, 1117\u20131130. https:\/\/doi.org\/10.1093\/cvr\/cvz050 (2019).","journal-title":"Cardiovasc. Res."},{"key":"73608_CR39","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman, P. C. et al. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J. Am. Coll. Cardiol. 67, 2050\u20132060. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.073 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"73608_CR40","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1038\/s41598-018-25143-y","volume":"8","author":"RCM de Jong","year":"2018","unstructured":"de Jong, R. C. M. et al. Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia\u2013reperfusion injury by suppression of the cardiac inflammatory response. Sci. Rep. 8, 6753. https:\/\/doi.org\/10.1038\/s41598-018-25143-y (2018).","journal-title":"Sci. Rep."},{"key":"73608_CR41","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1016\/S0021-9258(18)82232-3","volume":"268","author":"AM van den Maagdenberg","year":"1993","unstructured":"van den Maagdenberg, A. M. et al. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 268, 10540\u201310545 (1993).","journal-title":"J. Biol. Chem."},{"key":"73608_CR42","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1172\/JCI118532","volume":"97","author":"BJ van Vlijmen","year":"1996","unstructured":"van Vlijmen, B. J. et al. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. J. Clin. Investig. 97, 1184\u20131192. https:\/\/doi.org\/10.1172\/JCI118532 (1996).","journal-title":"J. Clin. Investig."},{"key":"73608_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0952-3278(97)90429-4","volume":"57","author":"LM Havekes","year":"1997","unstructured":"Havekes, L. M., van Vlijmen, B. J., Jong, M. C., van Dijk, K. W. & Hofker, M. H. Use of transgenic mice in lipoprotein metabolism and atherosclerosis research. Prostaglandins Leukot Essent Fatty Acids 57, 463\u2013466. https:\/\/doi.org\/10.1016\/s0952-3278(97)90429-4 (1997).","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"73608_CR44","doi-asserted-by":"publisher","first-page":"H2147","DOI":"10.1152\/ajpheart.1995.269.6.H2147","volume":"269","author":"LH Michael","year":"1995","unstructured":"Michael, L. H. et al. Myocardial ischemia and reperfusion: a murine model. Am. J. Physiol. 269, H2147-2154. https:\/\/doi.org\/10.1152\/ajpheart.1995.269.6.H2147 (1995).","journal-title":"Am. J. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73608-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:28:07Z","timestamp":1670358487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73608-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73608"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73608-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16601"}}